|Bid||160.00 x 800|
|Ask||0.00 x 800|
|Day's Range||178.86 - 182.75|
|52 Week Range||146.68 - 190.36|
|PE Ratio (TTM)||14.43|
|Earnings Date||Oct 23, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||198.81|
Nearly one in nine men, one in six African-American men, will be diagnosed with prostate cancer BOCA RATON, Fla. , Aug. 16, 2018 /PRNewswire/ -- Prostate cancer is the second most common cancer among men. ...
Durham County approved incentives worth nearly $450,000 combined Monday, including a package solidifying gene therapy firm AveXis’ 200-job expansion in the Triangle.
The acquisition of Covance Food Solutions by a European firm from Burlington-based LabCorp (LH: NYSE) is final. The $670 million deal, which Triad Business Journal reported in April, transfers ownership of the food testing company to Eurofins Scientific, a bioanaylitical testing firm located in Luxembourg. Eurofins Scientific (EUFI: PA) CEO Giles Martin said the opportunity to acquire such a high quality asset as Covance represents a clear milestone for his firm, pushing it further along in its goal toward building a testing platform with ”world-class infrastructure, science and IT solutions” by 2020. The business provides laboratory testing and consulting services for food and beverage products, and became a part of LabCorp when the Burlington-based company acquired Covance in 2015.
LabCorp's (LH) Covance Drug Development business has reported sturdy growth on strategic acquisitions, robust organic growth and a positive foreign currency translation.
LabCorp (LH) delivered earnings and revenue surprises of 2.05% and 0.59%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, July 25, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clearwater ...
The Burlington, North Carolina-based company said it had net income of $2.27 per share. Earnings, adjusted for amortization costs and restructuring costs, were $2.98 per share. The results beat Wall Street ...
NEW YORK, NY / ACCESSWIRE / July 25, 2018 / Laboratory Corporation of America Holdings (NYSE: LH ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 25, 2018 at 9:00 ...
BURLINGTON, N.C.-- -- Q2 revenue of $2.9 billion, up 13% over $2.5 billion last year Q2 diluted EPS of $2.27, up 28% from $1.78 last year; Q2 adjusted EPS of $2.98, up 23% over $2.43 last year Q2 free cash flow of $280 million, up 16% over $241 million last year 2018 adjusted EPS guidance of $11.35 to $11.65, up 23% to 26% over 2017 2018 free cash flow guidance of $1.1 billion to $1.2 billion LabCorp ...
Laboratory of America (NYSE: LH ) releases its next round of earnings Wednesday. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report. Earnings and Revenue Sell-side ...
The Medical product market further gains momentum on the back of a recent two-year suspension of the controversial 2.3% Medical Device tax.
The medical-testing giant Laboratory Corp. of America is dealing with a broad cyberattack, people familiar with the matter said, the latest breach to disrupt companies that hold sensitive information. The company, known as LabCorp, has said it was investigating suspicious activity but hasn’t previously disclosed publicly the nature or extent of the “ransomware” attack. It hit one of the company’s genetic-testing units over the weekend, and the impact spread in the ensuing days, the people said.
LabCorp has said that the 'suspicious activity' detected over the weekend was an attack by a 'new variant of ransomware.'
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding LH totaled $23 million.
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
LabCorp said there's no evidence of unauthorized transfer or misuse of data as a result of the breach.
LabCorp (LH) is expected to gain traction from a solid LabCorp Diagnostics segment in Q2, courtesy of a favorable price, mix, tuck-in acquisitions and organic volume.
LONDON, UK / ACCESSWIRE / July 16, 2018 / If you want a free Stock Review on IQV sign up now at www.wallstequities.com/registration. WallStEquities.com has selected the following Medical Laboratories and Research stocks for review this morning: iKang Healthcare Group Inc. (NASDAQ: KANG), Invitae Corp. (NYSE: NVTA), IQVIA Holdings Inc. (NYSE: IQV), and Laboratory Corp. of America Holdings (NYSE: LH).